Biodistribution of 68Ga-NODA-Aminoglucose in Intact and Tumor-Bearing Mice

[1]  I. Zavestovskaya,et al.  Experimental Study of the Biodistribution of New Bone-Seeking Compounds Based on Phosphonic Acids and Gallium-68 , 2020, Bulletin of Experimental Biology and Medicine.

[2]  Tang Gao,et al.  Nuclear Imaging of Glucose Metabolism: Beyond 18F-FDG , 2019, Contrast media & molecular imaging.

[3]  R. Krasikova,et al.  18F-FDG and Other Labeled Glucose Derivatives for Use in Radionuclide Diagnosis of Oncological Diseases (Review) , 2016, Pharmaceutical Chemistry Journal.

[4]  I. Velikyan.  68Ga-Based Radiopharmaceuticals: Production and Application Relationship , 2015, Molecules.

[5]  B. Barrios-Lopez,et al.  Radiolabeled Sugars Used for PET and SPECT Imaging. , 2015, Current radiopharmaceuticals.

[6]  D. Anastasiou.  Metabolic reprogramming in cancer cells , 2015 .

[7]  I. Velikyan.  Prospective of 68Ga-Radiopharmaceutical Development , 2013, Theranostics.

[8]  F Rösch,et al.  Past, present and future of 68Ge/68Ga generators. , 2013, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[9]  David J. Yang,et al.  Molecular Imaging of Mesothelioma with 99mTc-ECG and 68Ga-ECG , 2012, Journal of biomedicine & biotechnology.

[10]  Markus Jahn,et al.  Processing of Generator-Produced 68Ga for Medical Application , 2007, Journal of Nuclear Medicine.

[11]  K. Leung.  [18F]Fluoro-2-deoxy-2-D-glucose , 2005 .

[12]  C. Xiong,et al.  Synthesis and evaluation of (68)Ga-labeled DOTA-2-deoxy-D-glucosamine as a potential radiotracer in μPET imaging. , 2012, American journal of nuclear medicine and molecular imaging.